{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:56:07Z","timestamp":1793411767997,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221010-4\"><jats:title>Importance<\/jats:title><jats:p>Limited knowledge about interactions among health disorders impedes optimal patient care. Because comorbidities are common among patients 50 years and older with fractures, these fractures provide a useful setting for studying interactions among disorders.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221010-5\"><jats:title>Objective<\/jats:title><jats:p>To define multimorbidity clusters at the time of fracture and quantify the interaction between multimorbidity and fracture in association with postfracture excess mortality.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221010-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This nationwide cohort study included 307\u202f870 adults in Denmark born on or before January 1, 1951, who had an incident low-trauma fracture between January 1, 2001, and December 31, 2014, and were followed up through December 31, 2016. Data were analyzed from February 1 to March 31, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221010-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Fracture and 32 predefined chronic diseases recorded within 5 years before the index fracture were identified from the Danish National Hospital Discharge Register. Death was ascertained from the Danish Register on Causes of Death. Latent class analysis was conducted to identify multimorbidity clusters. Relative survival analysis was used to quantify excess mortality associated with the combination of multimorbidity and fractures at specific sites.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221010-8\"><jats:title>Results<\/jats:title><jats:p>Among the 307 870 participants identified with incident fractures, 95\u202f372 were men (31.0%; mean [SD] age at fracture, 72.3\u2009[11.2] years) and 212\u202f498 were women (69.0%; mean [SD] age at fracture, 74.9\u2009[11.2] years). During a median of 6.5 (IQR, 3.0-11.0) years of follow-up, 41\u202f017 men (43.0%) and 81\u202f727 women (38.5%) died. Almost half of patients with fractures (42.9%) had at least 2 comorbidities. Comorbidities at fracture were categorized as low-multimorbidity (60.5% in men and 66.5% in women), cardiovascular (23.7% in men and 23.5% in women), diabetic (5.6% in men and 5.0% in women), malignant (5.1% in men and 5.0% in women), and mixed hepatic and\/or inflammatory (5.1% in men only) clusters. These clusters distinguished individuals with advanced, complex, or late-stage disease from those with earlier-stage disease. Multimorbidity and proximal or lower leg fractures were associated with increased mortality risk, with the highest excess mortality found in patients with hip fracture in the malignant cluster (1-year excess mortality: 40.8% [95% CI: 38.1%-43.6%]). The combination of multimorbidity and fracture compounded the association with mortality, conferring much greater risk than either alone.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221010-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Concomitant illnesses were common and clustered into distinct multimorbidity clusters that were associated with excess postfracture mortality. The compound contribution of multimorbidity to postfracture excess mortality highlights the need for more comprehensive approaches in these high-risk patients. The analytical approach applied to fracture could also be used to examine other sentinel health events.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.35856","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:23:55Z","timestamp":1665415435000},"page":"e2235856","source":"Crossref","is-referenced-by-count":38,"title":["Association of Multimorbidity and Excess Mortality After Fractures Among Danish Adults"],"prefix":"10.1001","volume":"5","author":[{"given":"Thach","family":"Tran","sequence":"first","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"School of Biomedical Engineering, University of Technology, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Bliuc","sequence":"additional","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Ho-Le","sequence":"additional","affiliation":[{"name":"Faculty of Engineering and Information Technology, Ha Tinh University, Ha Tinh, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Abrahamsen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Holb\u00e6k Hospital, Holb\u00e6k, Denmark"},{"name":"Department of Clinical Research, Odense Patient Data Explorative Network, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop P.","family":"van den Bergh","sequence":"additional","affiliation":[{"name":"Research School NUTRIM (Nutrition and Translational Research in Metabolism), Subdivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Department of Internal Medicine, VieCuri Medical Center of Noord-Limburg, Venlo, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Eisman","sequence":"additional","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"School of Medicine Sydney, University of Notre Dame Australia, Sydney, New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Geusens","sequence":"additional","affiliation":[{"name":"Research School CAPHRI (Care and Public Health Research Institute), Subdivision of Rheumatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands"},{"name":"Biomedical Research Institute, University Hasselt, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Hansen","sequence":"additional","affiliation":[{"name":"Kontraktenheden, North Denmark Region, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Steno Diabetes Center North Jutland, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan V.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, University of Technology, Sydney, New South Wales, Australia"},{"name":"School of Medicine Sydney, University of Notre Dame Australia, Sydney, New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Blank","sequence":"additional","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline R.","family":"Center","sequence":"additional","affiliation":[{"name":"Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia"},{"name":"Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"School of Medicine Sydney, University of Notre Dame Australia, Sydney, New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"1","key":"zoi221010r1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/eurpub\/cky098","article-title":"Defining and measuring multimorbidity: a systematic review of systematic reviews.","volume":"29","author":"Johnston","year":"2019","journal-title":"Eur J Public Health"},{"issue":"9836","key":"zoi221010r2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"zoi221010r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025987","article-title":"Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines.","volume":"6","author":"Lugtenberg","year":"2011","journal-title":"PLoS One"},{"key":"zoi221010r4","doi-asserted-by":"publisher","first-page":"h176","DOI":"10.1136\/bmj.h176","article-title":"Managing patients with multimorbidity in primary care.","volume":"350","author":"Wallace","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"zoi221010r5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ageing\/afs100","article-title":"Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity.","volume":"42","author":"Hughes","year":"2013","journal-title":"Age Ageing"},{"issue":"2","key":"zoi221010r8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00198-017-4290-y","article-title":"Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.","volume":"29","author":"Vranken","year":"2018","journal-title":"Osteoporos Int"},{"issue":"5","key":"zoi221010r9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF03325146","article-title":"Comorbidity and mortality following hip fracture: a population-based cohort study.","volume":"20","author":"de Luise","year":"2008","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"zoi221010r10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10654-007-9211-5","article-title":"Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study.","volume":"23","author":"de Luise","year":"2008","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"zoi221010r11","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/jbmr.v32.9","article-title":"Population-wide impact of non-hip non-vertebral fractures on mortality.","volume":"32","author":"Tran","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"7","key":"zoi221010r12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores.","volume":"64","author":"Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi221010r13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"zoi221010r14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"10","key":"zoi221010r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i10","article-title":"poLCA: an R package for polytomous variable latent class analysis.","volume":"42","author":"Linzer","year":"2011","journal-title":"J Stat Softw"},{"issue":"11","key":"zoi221010r17","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10654-019-00568-5","article-title":"Do replicable profiles of multimorbidity exist? systematic review and synthesis.","volume":"34","author":"Busija","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"zoi221010r18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study.","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct Equ Modeling"},{"issue":"3","key":"zoi221010r19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/10705511.2014.915181","article-title":"Auxiliary variables in mixture modeling: three-step approaches using Mplus.","volume":"21","author":"Asparouhov","year":"2014","journal-title":"Struct Equ Modeling"},{"issue":"1","key":"zoi221010r20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Regression models for relative survival.","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat Med"},{"key":"zoi221010r21","first-page":"101","article-title":"The relative survival rate: a statistical methodology.","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"issue":"10141","key":"zoi221010r22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(18)31308-4","article-title":"Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach.","volume":"392","author":"Salisbury","year":"2018","journal-title":"Lancet"},{"key":"zoi221010r23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006560.pub3","article-title":"Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.","volume":"3","author":"Smith","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"zoi221010r24","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1001\/jama.2021.20739","article-title":"Contextualizing risk among patients with heart failure.","volume":"326","author":"Greene","year":"2021","journal-title":"JAMA"},{"issue":"20","key":"zoi221010r25","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1001\/archinternmed.2011.424","article-title":"Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions.","volume":"171","author":"Fried","year":"2011","journal-title":"Arch Intern Med"},{"key":"zoi221010r26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1472-6963-14-281","article-title":"Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness.","volume":"14","author":"May","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"5462","key":"zoi221010r27","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology: when an entire country is a cohort.","volume":"287","author":"Frank","year":"2000","journal-title":"Science"},{"issue":"7","key":"zoi221010r28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004694","article-title":"Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice.","volume":"4","author":"Harrison","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"zoi221010r29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11739-015-1213-9","article-title":"Use of administrative data in healthcare research.","volume":"10","author":"Mazzali","year":"2015","journal-title":"Intern Emerg Med"},{"issue":"3","key":"zoi221010r30","first-page":"263","article-title":"The Danish National Hospital Register: a valuable source of data for modern health sciences.","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"issue":"1","key":"zoi221010r31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/aje\/kwf007","article-title":"Fracture risk in patients with celiac disease, Crohn\u2019s disease, and ulcerative colitis: a nationwide follow-up study of 16 416 patients in Denmark.","volume":"156","author":"Vestergaard","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"2","key":"zoi221010r32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/14034940310017490","article-title":"The validity of self-reported fractures among Danish female nurses: comparison with fractures registered in the Danish National Hospital Register.","volume":"32","author":"Hundrup","year":"2004","journal-title":"Scand J Public Health"},{"issue":"8","key":"zoi221010r33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183817","article-title":"Multimorbidity in Australia: comparing estimates derived using administrative data sources and survey data.","volume":"12","author":"Lujic","year":"2017","journal-title":"PLoS One"},{"key":"zoi221010r16","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511499531","volume-title":"Applied Latent Class Analysis","author":"Hagenaars","year":"2002"},{"key":"zoi221010r6","unstructured":"National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management (NICE guideline 56). September 21, 2016. Accessed February 8, 2022. http:\/\/www.nice.org.uk\/guidance\/ng56"},{"key":"zoi221010r7","unstructured":"National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: treatment and management (clinical guideline 91). October 28, 2009. Accessed February 3, 2022. https:\/\/www.nice.org.uk\/Guidance\/CG91"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797069\/tran_2022_oi_221010_1664382858.09692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:24:08Z","timestamp":1665415448000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.35856","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}